Parse Biosciences Launches Evercode Whole Transcriptome V4 With Shorter Workflow, Higher Sensitivity and Higher Cell Recovery

Parse Biosciences, a QIAGEN company (NYSE: QGEN, Frankfurt Prime Standard: QIA), and the leading provider of scalable and ...

Atrandi Biosciences Redefines Single-Cell Multiomics with Expanded SPC Innovator Kit Portfolio

Company to showcase highly scalable and versatile capsule technology at the AGBT 2026 General Meeting Atrandi Biosciences, a life sciences tools company advancing single-cell analysis, today announced ...
TMCnet

Bruker Announces Major Advancements at AGBT to Enable Complete High-Fidelity Spatial Biology Across the Biological Spectrum

Bruker now extends their complete biology approach to mouse research by announcing development of the CosMx Mouse Whole ...
GEN - Genetic Engineering and Biotechnology News

ArgenTag, PacBio Partner on Long-Read Single-Cell Transcriptomics

ArgenTag joins PacBio to enable instrument-free single-cell kits to support long-read isoform sequencing at single-cell ...
Frontiers

Unraveling Immune Metabolism: Single-Cell & Spatial Transcriptomics Illuminate Disease Dynamics

The integration of single-cell and spatial transcriptomics with advanced metabolic profiling tools has revolutionized the ...

Atrandi Biosciences Brings Single-Cell Direct Multiomics Technology to SLAS 2026 Conference

Atrandi Biosciences, a life sciences tools company advancing single-cell analysis, today announced it will present new scientific data and platform innovations at the Society for Laboratory Automation ...
AZoLifeSciences on MSN

SeekGene joins Human Cell Atlas Consortium to advance multiomics research

SeekGene, a biotechnology company focused on "driving the development and democratization of innovative single-cell technologies", announced it has officially joined the Human Cell Atlas (HCA) ...
ascopubs.org

Amivantamab treatment and intra-tumoral gene expression and immune cell changes in refractory metastatic colorectal cancer (mCRC): Whole transcriptome RNA-sequencing analysis ...

Outcomes of young-onset colorectal cancer vs late-onset colorectal cancer patients on phase 1 matched and non-matched therapies. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I.